Earnings Feed
Start Free
Home/Filings/4/0001011438-06-000345
4//SEC Filing

ATHEROGENICS INC 4

Accession 0001011438-06-000345

CIK 0001107601operating
View on SEC.govCompany Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:48 PM ET

Size

22.7 KB

Accession

0001011438-06-000345

Insider Transaction Report

Form 4
Period: 2006-05-03
ATHEROGENICS INCAGIX
BARAKETT TIMOTHY R
10% Owner
Transactions
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.40/sh−2,632$3,685→ 0 total(indirect: See Note)
    Exercise: $30.00Exp: 2007-01-20→ Common Stock (263,200 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$6.67/sh−1,200$8,004→ 1,200 total(indirect: See Note)
    Exercise: $25.00Exp: 2008-01-18→ Common Stock (120,000 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$3.80/sh−2,400$9,120→ 0 total(indirect: See Note)
    Exercise: $15.00Exp: 2007-01-20→ Common Stock (240,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$5.67/sh−2,632$14,923→ 2,632 total(indirect: See Note)
    Exercise: $30.00Exp: 2008-01-18→ Common Stock (263,200 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.90/sh−1,200$2,280→ 0 total(indirect: See Note)
    Exercise: $25.00Exp: 2007-01-20→ Common Stock (120,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$9.32/sh−2,400$22,368→ 2,400 total(indirect: See Note)
    Exercise: $15.00Exp: 2008-01-18→ Common Stock (240,000 underlying)
Atticus Capital LP
10% Owner
Transactions
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$3.80/sh−2,400$9,120→ 0 total(indirect: See Note)
    Exercise: $15.00Exp: 2007-01-20→ Common Stock (240,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$9.32/sh−2,400$22,368→ 2,400 total(indirect: See Note)
    Exercise: $15.00Exp: 2008-01-18→ Common Stock (240,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$6.67/sh−1,200$8,004→ 1,200 total(indirect: See Note)
    Exercise: $25.00Exp: 2008-01-18→ Common Stock (120,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$5.67/sh−2,632$14,923→ 2,632 total(indirect: See Note)
    Exercise: $30.00Exp: 2008-01-18→ Common Stock (263,200 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.90/sh−1,200$2,280→ 0 total(indirect: See Note)
    Exercise: $25.00Exp: 2007-01-20→ Common Stock (120,000 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.40/sh−2,632$3,685→ 0 total(indirect: See Note)
    Exercise: $30.00Exp: 2007-01-20→ Common Stock (263,200 underlying)
ATTICUS CAPITAL LLC
10% Owner
Transactions
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$3.80/sh−2,400$9,120→ 0 total(indirect: See Note)
    Exercise: $15.00Exp: 2007-01-20→ Common Stock (240,000 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.40/sh−2,632$3,685→ 0 total(indirect: See Note)
    Exercise: $30.00Exp: 2007-01-20→ Common Stock (263,200 underlying)
  • Sale

    Stock Option (Right to Buy)

    2006-05-03$1.90/sh−1,200$2,280→ 0 total(indirect: See Note)
    Exercise: $25.00Exp: 2007-01-20→ Common Stock (120,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$9.32/sh−2,400$22,368→ 2,400 total(indirect: See Note)
    Exercise: $15.00Exp: 2008-01-18→ Common Stock (240,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$6.67/sh−1,200$8,004→ 1,200 total(indirect: See Note)
    Exercise: $25.00Exp: 2008-01-18→ Common Stock (120,000 underlying)
  • Purchase

    Stock Option (Right to Buy)

    2006-05-03$5.67/sh−2,632$14,923→ 2,632 total(indirect: See Note)
    Exercise: $30.00Exp: 2008-01-18→ Common Stock (263,200 underlying)
Footnotes (3)
  • [F1]Exercisable immediately.
  • [F2]This statement is being filed by Atticus Management LLC, f/k/a Atticus Capital, L.L.C., a Delaware limited liability company ("Atticus Management"). Atticus Capital LP, a Delaware limited partnership ("Atticus Capital") and Timothy R. Barakett are additional reporting persons (collectively with Atticus Management, the "Reporting Persons"). Effective as of January 1, 2006, Atticus Management effected a restructuring in which it assigned to Atticus Capital its rights and obligations under the investment management agreements with its clients and following the restructuring it changed its name to "Atticus Management LLC".
  • [F3]Mr. Barakett is the Chairman, Chief Executive Officer and Managing Member of Atticus Management. Atticus Management is the sole general partner of Atticus Capital. Atticus Capital, together with certain of its affiliated entities (collectively, the "Atticus Entities"), acts as adviser for various investment funds (the "Funds") and managed accounts (the "Accounts"). Based on his relationship with the Atticus Entities, Mr. Barakett is deemed to be a beneficial owner of the securities owned by the Funds and the Accounts for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934. Mr. Barakett, Atticus Management and Atticus Capital disclaim beneficial ownership within the meaning of Rule 16a-1(a)(2) under the Securities Exchange Act of 1934 in the Securities owned by the Funds and the Accounts except to the extent, if any, of their pecuniary interest therein.

Documents

2 files

Issuer

ATHEROGENICS INC

CIK 0001107601

→
Entity typeoperating
IncorporatedGA

Related Parties

1
  • filerCIK 0001107601

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:48 PM ET
Size
22.7 KB
View on SEC.gov